Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 21, 2016
Minimum Clinically Important Difference in the Calgary Depression Scale for Schizophrenia
I Amri, A Millier, M Toumi
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 21, 2016
Evolution of Presence of Predominant Negative Symptoms in Patients with Schizophrenia
T Refaï, A Millier, M Toumi
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 21, 2016
Burden Associated with Agitation in Schizophrenia
A Millier, I Amri, M Toumi
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 21, 2016
Minimum Clinically Important Difference in the Global Assessment Functioning in Patients with Schizophrenia
I Amri, A Millier, M Toumi
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 21, 2016
Population Access to Rotavirus Vaccination in Industrialized Countries: Lessons Learnt from Current Experience
M Toumi, S Aballea, A Millier
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 21, 2016
Evolution of Depressive Status in Patients with Schizophrenia: An Analysis of Patient Trajectories
A Millier, I Amri, M Toumi
Bulletin of Environmental Contamination and Toxicology
|
January 1, 1982
Biodegradation of trialkylacetic acid benzyl esters
A Millier, F Prost, P Chambon, et al.
Journal of Medical Economics
|
April 20, 2013
Assessing the economic impact of Rx-to-OTC switches: systematic review and guidelines for future development
J Cohen, A Millier, S Karray, et al.
Community Mental Health Journal
|
April 4, 2014
Evaluation of different approaches for confounding in nonrandomised observational data: a case-study of antipsychotics treatment
E Sarlon, A Millier, S Aballéa, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 21, 2016
Should Changes in Drug Price Over Time be Considered in Cost-Effectiveness Analyses?
A Millier, B Briquet, S Aballea, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 21, 2016
Minimum Clinically Important Difference in the Calgary Depression Scale for Schizophrenia
I Amri, A Millier, M Toumi
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 21, 2016
Evolution of Presence of Predominant Negative Symptoms in Patients with Schizophrenia
T Refaï, A Millier, M Toumi
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 21, 2016
Burden Associated with Agitation in Schizophrenia
A Millier, I Amri, M Toumi
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 21, 2016
Minimum Clinically Important Difference in the Global Assessment Functioning in Patients with Schizophrenia
I Amri, A Millier, M Toumi
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 21, 2016
Population Access to Rotavirus Vaccination in Industrialized Countries: Lessons Learnt from Current Experience
M Toumi, S Aballea, A Millier
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 21, 2016
Evolution of Depressive Status in Patients with Schizophrenia: An Analysis of Patient Trajectories
A Millier, I Amri, M Toumi
Bulletin of Environmental Contamination and Toxicology
|
January 1, 1982
Biodegradation of trialkylacetic acid benzyl esters
A Millier, F Prost, P Chambon, et al.
Journal of Medical Economics
|
April 20, 2013
Assessing the economic impact of Rx-to-OTC switches: systematic review and guidelines for future development
J Cohen, A Millier, S Karray, et al.
Community Mental Health Journal
|
April 4, 2014
Evaluation of different approaches for confounding in nonrandomised observational data: a case-study of antipsychotics treatment
E Sarlon, A Millier, S Aballéa, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 21, 2016
Should Changes in Drug Price Over Time be Considered in Cost-Effectiveness Analyses?
A Millier, B Briquet, S Aballea, et al.
Page
of 2